If this observation is confirmed, further studies could examine other clinical and biological features such as the expression of inflammatory cytokines, tumour ulceration, regional differences in the distribution of hsp expression (for example, proximity to the invasive front, necrotic core or blood vessels), histological sub-type or other factors that may interact with or separately explain this observation. This evidence concerns the gene HSP90B2P and neoplasm.